Answers are grounded in this paper and cite their sources.
Case report reveals rare occurrence of bilateral pheochromocytomas in a patient with NCCAH and a MAX mutation, indicating a unique genetic link.
We present the case of a patient with bilateral pheochromocytomas and newly diagnosed nonclassical congenital adrenal hyperplasia (NCCAH). While NCCAH is relatively common, pheochromocytomas are extremely rare. The patient is a 29-year-old woman who was referred for investigation of hirsutism, with a past medical history of hypertension since the age of 18 and precocious pubarche. Magnetic resonance imaging (MRI) showed a right adrenal mass of 4.4 × 4.7 cm and a left adrenal mass of 2.9 × 2.9 cm. Biochemical testing confirmed NCCAH and also revealed elevated 24-hour urinary catecholamines, as well as increased plasma metanephrines. The patient underwent bilateral adrenalectomy, which confirmed the diagnosis of bilateral pheochromocytomas. Genetic testing identified a heterozygous pathogenic germline variant in the MAX gene (deletion exons 1-2) that led to complete loss of expression of MAX in the tumors. Moreover, CYP21A2 gene sequencing revealed a germline homozygous CYP21A2 c.844G> T (p.Val282Leu) pathogenic variant supporting the diagnosis of NCCAH. In summary, this case presents the rare coexistence of bilateral pheochromocytomas with a germline MAX pathogenic variant and NCCAH.
No takes yet. Share an insight, caveat, or question.
Salle et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: